CERO THERAPEUTICS HOLDINGS, INC. Total Liabilities
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Total Liabilities of $32.41 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-14
- 2026-06-30: Liabilities $32.41M.
- 2026-03-31: Liabilities $11.46M.
- 2025-12-31: Liabilities $9.09M.
- 2025-09-30: Liabilities $8.45M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $32.41M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.46M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $9.09M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $8.45M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $7.84M 10-Q · filed 2025-08-22 | |
| 2025-03-31 | $8.32M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $8.10M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $10.19M 10-Q/A · filed 2024-11-20 | |
| 2024-06-30 | $9.85M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $13.03M 10-Q · filed 2024-05-17 | |
| 2023-12-31 | $5.08M 10-K · filed 2025-04-15 | $14.32M 10-K · filed 2024-04-02 |
| 2023-09-30 | $13.95M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $13.56M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $12.44M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $39.90M 10-K · filed 2024-04-02 | |
| 2022-09-30 | $10.03M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $9.38M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $9.32M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $9.25M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $277.00K 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |